ArticleJournal of human hypertension2025
"Clinical prediction model for masked hypertension diagnosed by 24-h ambulatory blood pressure measurements in a sample from specialized hospital."
Article in Journal of human hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detection of masked hypertension in patients with metabolic-dysfunction associated steatotic liver disease using a novel clinical risk model.Journal of human hypertension · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The conventional assessment of the relationship between arterial hypertension (AH) and cardiovascular damage has predominantly relied on office measurements. However, the diagnostic significance of ambulatory and home measurements has gained prominence, particularly in identifying distinct AH phenotypes like masked hypertension (MH), characterized by normal office values but elevated readings outside the clinical setting, carrying comparable risks to sustained AH. Current guidelines advocate for Ambulatory Blood Pressure Monitoring (ABPM) in individuals with office values exceeding 130/85 mmHg. This study aims to develop a clinical prediction model to identify masked hypertension in individuals with normal office blood pressure and to create a clinical score.A cross-sectional study was conducted in a secondary level hospital, including patients aged 18-85 years with average office blood pressure <140/90 mmHg who underwent a valid ABPM on the same day. Pregnant and postpartum women were excluded. A multivariable logistic regression model with calibration, discrimination, and stability parameters was applied to predict masked hypertension. 506 individuals with valid ABPM were analysed. The prevalence of masked hypertension was 30.8%. The selected variables were: diastolic blood pressure, pulse pressure, waist diameter and sex. The model calibrated adequately (Hosmer-Lemeshow test p = 0.35), with an AUC of 0.72 (95% CI, 0.67-0.77). Significant differences existed between the traditional and the new models (p < 0.001). A user-friendly clinical model was developed, with a clinical score achieving 90% specificity using an estimated probability of 0.4 with a 10-point score.A novel model, performed with easily collectable clinical variables, showed robust calibration, stability, and discrimination. It outperforms sole reliance on office blood pressure, exhibiting high specificity (~90%) for masked hypertension detection. Its internal validity suggests a potential for enhanced masked hypertension identification.
Indexed as
Identifiers
39604681What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.